{
  "docId": "019de071-ad50-74b5-a3e2-f84a5c6da821",
  "docSlug": "ef6dcb0c44baedac7204a3bdb460432b",
  "documentTitle": "AbCellera | Results Presentation Deck | 20 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 20,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "thesis_headline",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The graphic represents a transmembrane protein structure, illustrating the 'difficult-to-drug' nature of these targets.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-ad50-74b5-a3e2-f84a5c6da821/8",
  "deckHref": "/decks/019de071-ad50-74b5-a3e2-f84a5c6da821",
  "deckJsonHref": "/decks/019de071-ad50-74b5-a3e2-f84a5c6da821.json",
  "deckAnchorHref": "/decks/019de071-ad50-74b5-a3e2-f84a5c6da821#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.24,
        "w": 0.266,
        "x": 0.638,
        "y": 0.543
      },
      "kind": "image",
      "text": "Graphic representation of a transmembrane protein",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58c59166-5fca-4c54-acc8-e2db16953fb0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.42,
        "x": 0.09,
        "y": 0.45
      },
      "kind": "paragraph",
      "text": "GPCR and ion channel proteins are high value, difficult-to-drug targets.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3e767e28-312a-4fdd-be0c-9a18334dd136",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.42,
        "x": 0.09,
        "y": 0.62
      },
      "kind": "paragraph",
      "text": "Integrating TetraGenetics into our tech stack provides an optimized source of proteins for our antibody discovery efforts and solves a key challenge in pursuing these highly sought-after, but difficult-to-drug targets.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fca6880e-f366-4bbb-a8f0-a56ff0343558",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.82,
        "x": 0.09,
        "y": 0.13
      },
      "kind": "title",
      "text": "EXPAND CAPABILITIES AGAINST DIFFICULT-TO-DRUG TARGETS WITH ACQUISITION OF TETRAGENETICS",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a68ae5c6-fc43-467a-aedf-cd681ed37e18",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}